Gengzhen Zhu

1 Patent

• US118979662024

  Mesothelin-targetting Antibodies, Chimeric Antigen Receptors, and Uses Thereof

  UTC THERAPEUTICS (SHANGHAI) CO., Ltd.

  0 cites